TRANSCRIPTOMIC AND PROTEOMIC ANALYSES OF DIPG RESPONSE TO ONC201

被引：0

作者：

Sridharan, Sreepradha ^{[1
]}

Harmanci, Arif ^{[2
]}

Sharma, Ajay ^{[1
]}

Lai, Yanlai ^{[1
]}

Kennis, Bridget ^{[1
]}

Dobson, Tara ^{[1
]}

Swaminathan, Jyothishmathi ^{[1
]}

Haltom, Amanda ^{[1
]}

Khatua, Soumen ^{[1
]}

Tarapore, Rohinton ^{[3
]}

Allen, Joshua ^{[3
]}

Cheng, Donghang ^{[1
]}

Zaky, Wafik ^{[1
]}

Gopalakrishnan, Vidya ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA

[2] Univ Texas Hlth Sci Ctr Houston, Ctr Precis Hlth, Houston, TX 77030 USA

[3] Oncoceutics Inc, Philadelphia, PA USA

来源：

NEURO-ONCOLOGY | 2020年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

DIPG-57

引用

页码：298 / 298

页数：1

共 50 条

[1] ONC201 TARGETING IN DIPG
Abuarqoub, Alqassem
McAnulty, Tatiana
Amiel, Eyal
Stafford, James
NEURO-ONCOLOGY, 2021, 23 : 24 - 25
[2] REVEALING VULNERABILITIES IN DIPG THROUGH ONC201
Stafford, James
Abuarqoub, Alqassem
Mcanulty, Tatiana
Possemato, Richard
Amiel, Eyal
Snuderl, Matija
NEURO-ONCOLOGY, 2021, 23 : 26 - 26
[3] STUDY OF ONC201 IN PRE-CLINICAL MODELS OF DIPG
Sharma, Ajay
Lai, Yanlai
Kennis, Bridget
Sridharan, Sreepradha
Dobson, Tara
Swaminathan, Jyothishmathi
Khatua, Soumen
Sandberg, David
Allen, Joshua
Tarapore, Rohinton
Gopalakrishnan, Vidya
Zaky, Wafik
NEURO-ONCOLOGY, 2019, 21 : 192 - 192
[4] AKT SIGNALING DRIVES RESISTANCE TO ONC201 IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
Jackson, Evangeline R.
Duchatel, Ryan J.
Mannan, Abdul
Hulleman, Esther
Carcaboso, Angel M.
Monje, Michelle
McCowage, Geoff B.
Alvaro, Frank
Dun, Matthew D.
NEURO-ONCOLOGY, 2020, 22 : 293 - 293
[5] ROLE OF CLPP AND MITOCHONDRIAL METABOLISM IN THE ANTI-CANCER EFFECTS OF IMIPRIDONE ONC201 AND ONC206 IN GLIOBLASTOMA AND DIPG
Foster, Scott
Lee, Andrew
Maranto, Cristina
Allen, Joshua E.
Lanier, Randall
Sethna, Phiroze
Prabhu, Varun V.
NEURO-ONCOLOGY, 2022, 24 : 234 - 234
[6] ONC201: Stressing tumors to death
Greer, Yoshimi Endo
Lipkowitz, Stanley
SCIENCE SIGNALING, 2016, 9 (415)
[7] Preclinical studies of the combination of ONC201, radiotherapy and Temozolomide against GBM, DIPG and ATRT cell lines
Zhou, Lanlan
El-Deiry, Wafik S.
CANCER RESEARCH, 2019, 79 (13)
[8] MOLECULAR DIFFERENTIATION OF IMIPRIDONES ONC201 AND ONC206
Prabhu, Varun
Cuoco, Caroline
Jung, Jinkyu
Morrow, Sara
Kawakibi, Abed Rahman
Willette, Blair
Day, Marilyn
Anantharaman, Lakshmi
Charter, Neil
Rucker, Joseph
Doranz, Benjamin
Basken, Joel
Stogniew, Martin
Gilbert, Mark
Free, R.
Sibley, David
Allen, Joshua
NEURO-ONCOLOGY, 2020, 22 : 68 - 68
[9] ONC201 shows promise in AML treatment
Edwards, Holly
Ge, Yubin
CELL CYCLE, 2018, 17 (03) : 277 - 277
[10] CLINICAL EVALUATION OF THE IMIPRIDONE ONC201 IN RECURRENT GLIOBLASTOMA: PREDICTIVE AND PHARMACODYNAMIC BIOMARKER ANALYSES
Arrillaga-Romany, Isabel
Allen, Joshua E.
Prabhu, Varun V.
Tarapore, Rohinton S.
Zloza, Andrew
Oster, Wolfgang
Wen, Patrick Y.
Batchelor, Tracy
NEURO-ONCOLOGY, 2017, 19 : 11 - 12

← 1 2 3 4 5 →